Vivitrol
Payments companies reported to CMS as associated with Vivitrol. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vivitrol, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vivitrol
These are the largest totals companies reported as associated with Vivitrol. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Arwen Podesta | New Orleans, LA | Psychiatry | $86,659.76 |
| Michael Measom | Slc, UT | Psychiatry | $83,442.61 |
| Matthew Pabis | New York, NY | Family Medicine | $74,608.43 |
| Stacy Cohen | Santa Monica, CA | Psychiatry | $68,965.68 |
| Amberly Chaplin | Worcester, MA | Nurse Practitioner | $55,828.14 |
| Janet Wilkinson | Mora, MN | Nurse Practitioner | $37,445.77 |
| Christopher Davis | York, PA | Addiction Medicine (Internal Medicine) | $36,076.61 |
| Arturo Taca | Creve Coeur, MO | Psychiatry | $34,772.36 |
| Kenneth Starr | Arroyo Grande, CA | Addiction Medicine (Internal Medicine) | $34,722.22 |
| Mallory Capps | Bel Aire, KS | Family | $29,383.93 |
Prescribed Vivitrol?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.